BlackRock Amends Biogen Stake, Signals Ownership Change
Ticker: BIIB · Form: SC 13G/A · Filed: 2024-01-24T00:00:00.000Z
Sentiment: neutral
Topics: institutional-ownership, amendment, biotech
TL;DR
**BlackRock updated its Biogen stake, watch for potential market reaction.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 24, 2024, disclosing its ownership of Biogen Inc. common stock as of December 31, 2023. This amendment, number 14, indicates a change in BlackRock's beneficial ownership, which is important for investors as BlackRock is a major institutional investor and its movements can signal shifts in market sentiment or investment strategy regarding Biogen. This matters to current or prospective Biogen shareholders because large institutional holdings can influence stock stability and future price movements.
Why It Matters
This filing shows BlackRock's updated position in Biogen, which can influence other investors' perceptions and potentially impact Biogen's stock price due to the sheer size of BlackRock's investments.
Risk Assessment
Risk Level: low — This is a routine update from a large institutional investor and does not inherently signal high risk, though changes in ownership can have minor market impacts.
Analyst Insight
Investors should monitor future BlackRock filings for Biogen to track any significant changes in their ownership percentage, as large shifts could indicate a change in their investment thesis for the company.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- BIOGEN INC. (company) — the subject company whose shares are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 24, 2024 (date) — the filing date of the SC 13G/A
- Amendment No: 14 (number) — the specific amendment number for this filing
Forward-Looking Statements
- BlackRock will continue to be a significant institutional holder of Biogen stock. (BlackRock Inc.) — high confidence, target: 2025-12-31
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, filed under Rule 13d-1(b) of the Securities Exchange Act of 1934.
Who is the 'subject company' in this filing?
The subject company is BIOGEN INC., identified by CIK 0000875045 and CUSIP Number 09062X103.
Who is the 'filed by' entity in this document?
The entity that filed this document is BlackRock Inc., identified by CIK 0001364742.
What was the 'Date of Event Which Requires Filing of this Statement'?
The date of the event which requires the filing of this statement was December 31, 2023.
What is the 'Amendment No.' for this specific filing?
This specific filing is Amendment No: 14 to the Schedule 13G for BIOGEN INC.
From the Filing
EDGAR Filing Documents for 0001086364-24-002278 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] SEC Accession No. 0001086364-24-002278 Filing Date 2024-01-24 Accepted 2024-01-24 14:27:13 Documents 1 Document Format Files Seq Description Document Type Size 1 us09062x1037_012424.txt SC 13G/A 12002 Complete submission text file 0001086364-24-002278.txt 14079 Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142 Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000 BIOGEN INC. (Subject) CIK : 0000875045 (see all company filings) EIN. : 330112644 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G/A | Act: 34 | File No.: 005-42028 | Film No.: 24555798 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences) Mailing Address 50 HUDSON YARDS NEW YORK NY 10001 Business Address 50 HUDSON YARDS NEW YORK NY 10001 212-810-5300 BlackRock Inc. (Filed by) CIK : 0001364742 (see all company filings) EIN. : 320174431 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G/A SIC : 6211 Security Brokers, Dealers & Flotation Companies (CF Office: 02 Finance)